PDTM-33. ATRX LOSS CONFERS ENHANCED SENSITIVITY TO COMBINED PARP INHIBITION AND RADIOTHERAPY IN PAEDIATRIC GLIOBLASTOMA MODELS
Janat Fazal Salom(Institute of Cancer Research), Chris Jones(North Carolina State University), Darren Hargrave(Great Ormond Street Hospital), Fernando Carceller, Matthew Clarke(Institute of Cancer Research), Valeria Molinari(Institute of Cancer Research), Andrew S. Moore(Children's Health Queensland Hospital and Health Service), Chris Lord, Simon Robinson, Helen N. Pemberton(Institute of Cancer Research), Alan Mackay(Institute of Cancer Research), Diana Carvalho(Institute of Cancer Research), Lynley V. Marshall(Royal Marsden Hospital), Ángel M. Carcaboso(Hospital Sant Joan de Déu Barcelona), Maria Vinci(Cancer Research UK), Lynn Bjerke(Institute of Cancer Research), Jessica K.R. Boult(Institute of Cancer Research)
Cited by 5
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k